Akrivis Technologies
Joel Berniac is the CEO, President & Vice-Chairman of the Board of Managers at Akrivis Technologies. Joel brings over 10 years of experience and expertise in drug discovery and business development in the pharmaceutical industry. Previously, Joel was an Associate Director of Business Development at Paratek Pharmaceuticals, Inc.
Joel earned his Ph.D. in Organic Chemistry from the University of Notre Dame in 1999.
This person is not in any teams
This person is not in any offices
Akrivis Technologies
Akrivis Technologies, LLC is a privately-held biopharmaceutical company founded in 2009 and headquartered in Cambridge, MA. Akrivis is engaged in the early diagnosis and treatment of serious and life-threatening diseases.